Who is taking the lead in the development of drugs for Alzheimer’s Disease

Patent Analytics Open Webinar

Who is taking the lead in the development of drugs for Alzheimer’s Disease?

To watch the recording, please submit the form below:

Watch the Recording

Presenters

Andreas Lübbering
Andreas Lübbering
Senior Customer Success Manager
PatentSight
Donghyun Kim
Donghyun Kim
Consultant
PatentSight

Who is taking the lead in the development of drugs for Alzheimer’s Disease?

As of today, there are no drugs that can cure Alzheimer’s: every 65 seconds someone in the US develops the disease. Alzheimer’s disease, is now the second leading cause of death in Australians.
 
Take a look at the current innovation landscape of drugs and treatments for Alzheimer's, and find out who is most likely to take the lead of this billion-dollar market.
 
What you will learn in this webinar:
 
  • The global IP landscape of technologies related to treating and diagnosing Alzheimer’s
  • How to use legal status information to evaluate the current value of Alzheimer’s-related IP
  • The importance of ownership data for identifying the strongest patent portfolios
  • Use of smart analytics vs. patent activity statistics